| Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies B Darvishi, K Majidzadeh-A, R Ghadirian, M Mosayebzadeh, ... Life sciences 217, 34-40, 2019 | 25 | 2019 |
| Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function S Moradi-Kalbolandi, A Sharifi-K, B Darvishi, K Majidzadeh-A, S Sadeghi, ... Molecular immunology 118, 174-181, 2020 | 15 | 2020 |
| Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors P Merikhian, B Darvishi, N Jalili, MR Esmailinejad, AS Khatibi, ... Molecular oncology 16 (2), 485-507, 2022 | 14 | 2022 |
| Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo M Samadi, K Majidzadeh-A, M Salehi, N Jalili, Z Noorinejad, ... Journal of Biological Engineering 15, 1-15, 2021 | 14 | 2021 |
| Evaluation of apoptosis in the lung tissue of sulfur mustard-exposed individuals M Mosayebzadeh, T Ghazanfari, A Delshad, H Akbari Iranian Journal of Allergy, Asthma and Immunology, 283-288, 2016 | 9 | 2016 |
| Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo (vol 15, 20, 2021) M Samadi, K Majidzadeh-A, M Salehi, N Jalili, Z Noorinejad, ... JOURNAL OF BIOLOGICAL ENGINEERING 16 (1), 2022 | | 2022 |
| Correction: Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo M Samadi, K Majidzadeh-A, M Salehi, N Jalili, Z Noorinejad, ... Journal of Biological Engineering 16, 2022 | | 2022 |
| Tumor specific hypoxia-activated expression of cardiac peptides using an engineered subtype of Escherichia coli suppresses tumor growth, angiogenesis and metastasis in mouse … B Darvishi, K Majidzadeh, N Jalili, Z Noorinejad, A Sharifkhatibi, S Moradi, ... Authorea Preprints, 2020 | | 2020 |
